AP338A - A carbamoylchroman compound as selective 5-hydroxytryptamine. - Google Patents

A carbamoylchroman compound as selective 5-hydroxytryptamine. Download PDF

Info

Publication number
AP338A
AP338A APAP/P/1992/000434A AP9200434A AP338A AP 338 A AP338 A AP 338A AP 9200434 A AP9200434 A AP 9200434A AP 338 A AP338 A AP 338A
Authority
AP
ARIPO
Prior art keywords
compound
isopropyl
propylamino
carbamoylchroman
treatment
Prior art date
Application number
APAP/P/1992/000434A
Other languages
English (en)
Other versions
AP9200434A0 (en
Inventor
Eva Maria Hammarberg
Lars George Johansson
Svante Bertil Ross
Seth Olov Thornberg
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9102905A external-priority patent/SE9102905D0/xx
Priority claimed from SE9202000A external-priority patent/SE9202000D0/xx
Application filed by Ab Astra filed Critical Ab Astra
Publication of AP9200434A0 publication Critical patent/AP9200434A0/xx
Application granted granted Critical
Publication of AP338A publication Critical patent/AP338A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1992/000434A 1991-10-08 1992-10-08 A carbamoylchroman compound as selective 5-hydroxytryptamine. AP338A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9102905A SE9102905D0 (sv) 1991-10-08 1991-10-08 A new therapeutically active compound and a process for its preparation
SE9202000A SE9202000D0 (sv) 1992-06-29 1992-06-29 A new therapeutically active compound

Publications (2)

Publication Number Publication Date
AP9200434A0 AP9200434A0 (en) 1992-10-31
AP338A true AP338A (en) 1994-04-26

Family

ID=26661197

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000434A AP338A (en) 1991-10-08 1992-10-08 A carbamoylchroman compound as selective 5-hydroxytryptamine.

Country Status (32)

Country Link
EP (3) EP0703229A3 (fr)
JP (1) JPH07500320A (fr)
CN (2) CN1072411A (fr)
AP (1) AP338A (fr)
AT (1) ATE139774T1 (fr)
AU (1) AU667687B2 (fr)
BG (1) BG98684A (fr)
CA (1) CA2118708A1 (fr)
CY (1) CY1992A (fr)
CZ (1) CZ51094A3 (fr)
DE (1) DE69211857T2 (fr)
DK (1) DK0607274T3 (fr)
EE (1) EE02981B1 (fr)
ES (1) ES2089571T3 (fr)
FI (1) FI941616A (fr)
GR (1) GR3020608T3 (fr)
HK (1) HK55997A (fr)
HR (1) HRP920935A2 (fr)
HU (1) HUT68834A (fr)
IL (1) IL103373A0 (fr)
IS (2) IS1644B (fr)
MA (1) MA22674A1 (fr)
MX (1) MX9205744A (fr)
MY (1) MY131174A (fr)
NO (1) NO941256L (fr)
NZ (2) NZ270595A (fr)
PL (1) PL171013B1 (fr)
SI (1) SI9200249A (fr)
SK (1) SK36194A3 (fr)
TN (1) TNSN92088A1 (fr)
WO (1) WO1993007135A1 (fr)
YU (1) YU90492A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
CA2345079C (fr) * 1998-09-23 2011-06-21 Research Development Foundation Tocopherols, tocotrienols, autres derives de chromane et de chaines laterales et leurs utilisations
US6235938B1 (en) * 1999-06-10 2001-05-22 Yale University Transition metal-catalyzed process for preparing N-aryl amine compounds
KR20190065246A (ko) 2016-07-29 2019-06-11 선오비온 파마슈티컬스 인코포레이티드 화합물 및 조성물 및 이들의 용도
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009853A1 (fr) * 1989-12-22 1991-07-11 Aktiebolaget Astra Nouveaux derives du chroman et du thiochroman

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3679378D1 (de) * 1985-09-03 1991-06-27 Ciba Geigy Ag 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
JPH021429A (ja) * 1988-06-09 1990-01-05 Toray Ind Inc 光学活性１−メチル−３−フェニルプロピルアミンの製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009853A1 (fr) * 1989-12-22 1991-07-11 Aktiebolaget Astra Nouveaux derives du chroman et du thiochroman

Also Published As

Publication number Publication date
WO1993007135A1 (fr) 1993-04-15
TNSN92088A1 (fr) 1993-06-08
HRP920935A2 (en) 1995-08-31
ES2089571T3 (es) 1996-10-01
PL171013B1 (pl) 1997-02-28
ATE139774T1 (de) 1996-07-15
EP0607274B1 (fr) 1996-06-26
HUT68834A (en) 1995-08-28
DE69211857D1 (de) 1996-08-01
HK55997A (en) 1997-05-09
MX9205744A (es) 1993-04-01
EE02981B1 (et) 1997-04-15
FI941616A0 (fi) 1994-04-08
NO941256D0 (no) 1994-04-07
AP9200434A0 (en) 1992-10-31
JPH07500320A (ja) 1995-01-12
AU2768492A (en) 1993-05-03
IS3929A (is) 1993-04-09
IL103373A0 (en) 1993-03-15
CY1992A (en) 1997-09-05
IS1644B (is) 1997-03-25
AU667687B2 (en) 1996-04-04
BG98684A (en) 1995-05-31
EP0703229A3 (fr) 1996-06-26
SK36194A3 (en) 1994-12-07
EP0703229A2 (fr) 1996-03-27
NZ244618A (en) 1996-10-28
CZ51094A3 (en) 1994-11-16
EP0538222A1 (fr) 1993-04-21
CN1146992A (zh) 1997-04-09
NO941256L (no) 1994-04-07
MA22674A1 (fr) 1993-07-01
CA2118708A1 (fr) 1993-04-15
NZ270595A (en) 1996-10-28
MY131174A (en) 2007-07-31
CN1072411A (zh) 1993-05-26
HU9400993D0 (en) 1994-08-29
EP0607274A1 (fr) 1994-07-27
SI9200249A (en) 1993-06-30
FI941616A (fi) 1994-04-08
DK0607274T3 (da) 1996-11-04
IS4310A (is) 1993-04-09
YU90492A (sh) 1995-12-04
GR3020608T3 (en) 1996-10-31
DE69211857T2 (de) 1996-10-24

Similar Documents

Publication Publication Date Title
US5650524A (en) Process for preparing (R)-3-amino-5-methoxychroman
US6596722B2 (en) Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
US5962514A (en) Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist
FR2832713A1 (fr) Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
SI9012429A (en) New chroman and thiochroman derivatives
FR2832712A1 (fr) Derives de 4-(oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]nonane, leur preparation et leur application en therapeutique
IL131999A (en) Benzocycloheptathiophene compounds and pharmaceutical compositions comprising them
KR20220004174A (ko) GlyT1 억제제의 고체 형태
AP338A (en) A carbamoylchroman compound as selective 5-hydroxytryptamine.
CZ286038B6 (cs) Derivát v poloze 8-substituovaného 2-aminotetralinu, způsoby jeho přípravy, farmaceutický prostředek s jeho obsahem a použití
WO2006010968A1 (fr) Nouveaux dérivés d'amide d'acide aryloxy-acétique
US5616610A (en) (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
JP3786984B2 (ja) ピペラジン誘導体